JP7232526B2 - コアシェル型マイクロニードル装置及びその使用 - Google Patents

コアシェル型マイクロニードル装置及びその使用 Download PDF

Info

Publication number
JP7232526B2
JP7232526B2 JP2019529985A JP2019529985A JP7232526B2 JP 7232526 B2 JP7232526 B2 JP 7232526B2 JP 2019529985 A JP2019529985 A JP 2019529985A JP 2019529985 A JP2019529985 A JP 2019529985A JP 7232526 B2 JP7232526 B2 JP 7232526B2
Authority
JP
Japan
Prior art keywords
peroxide
glucose
insulin
pva
sensitive linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019529985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020512283A (ja
JP2020512283A5 (https=
Inventor
グ，チェン
ワン，ジンチャン
エ，ヤンチ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Carolina State University
Original Assignee
North Carolina State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Carolina State University filed Critical North Carolina State University
Publication of JP2020512283A publication Critical patent/JP2020512283A/ja
Publication of JP2020512283A5 publication Critical patent/JP2020512283A5/ja
Application granted granted Critical
Publication of JP7232526B2 publication Critical patent/JP7232526B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6955—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a plaster, a bandage, a dressing or a patch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01006—Catalase (1.11.1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
JP2019529985A 2016-12-05 2017-12-05 コアシェル型マイクロニードル装置及びその使用 Active JP7232526B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662430260P 2016-12-05 2016-12-05
US62/430,260 2016-12-05
PCT/US2017/064723 WO2018106696A1 (en) 2016-12-05 2017-12-05 Core-shell microneedle devices and uses thereof

Publications (3)

Publication Number Publication Date
JP2020512283A JP2020512283A (ja) 2020-04-23
JP2020512283A5 JP2020512283A5 (https=) 2022-02-09
JP7232526B2 true JP7232526B2 (ja) 2023-03-03

Family

ID=62491316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019529985A Active JP7232526B2 (ja) 2016-12-05 2017-12-05 コアシェル型マイクロニードル装置及びその使用

Country Status (7)

Country Link
US (2) US11697007B2 (https=)
EP (2) EP3548135B1 (https=)
JP (1) JP7232526B2 (https=)
CN (1) CN110167624B (https=)
CA (1) CA3045882A1 (https=)
DK (1) DK3548135T3 (https=)
WO (1) WO2018106696A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3548135T3 (da) * 2016-12-05 2021-11-22 Univ North Carolina State Kerne-skal-mikronålsindretninger og anvendelser deraf
US12109032B1 (en) 2017-03-11 2024-10-08 Biolinq Incorporated Methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure
US12599337B1 (en) 2017-08-08 2026-04-14 Biolinq Incorporated Method and system for confirmation of microneedle-based analyte-selective sensor insertion into viable tissue via electrical interrogation
WO2019143293A1 (en) * 2018-01-16 2019-07-25 Nanyang Technological University Self-implantable micro-drug-reservoirs for localized and controlled ocular drug delivery
US11724941B2 (en) 2018-02-15 2023-08-15 North Carolina State University Synthesis of micron and nanoscale carbon spheres and structures using hydrothemal carbonization
US20210145984A1 (en) * 2018-04-13 2021-05-20 North Carolina State University Ros-responsive microneedle patch for acne vulgaris treatment
JP2021533934A (ja) 2018-08-24 2021-12-09 ノース カロライナ ステート ユニバーシティNorth Carolina State University 閉ループインスリン送達用のグルコース応答性マトリックスを備えたマイクロニードルアレイパッチ
WO2020041694A1 (en) * 2018-08-24 2020-02-27 North Carolina State University Stem cell microneedle patch for treating heart diseases
EP3852721A4 (en) * 2018-09-20 2022-06-29 Singapore Health Services Pte Ltd Conductive microneedle patch for active agent delivery
CN109675185A (zh) * 2019-01-02 2019-04-26 浙江大学 一种苯硼酸水凝胶基糖敏微针贴及其制备方法
JP2021153914A (ja) * 2020-03-27 2021-10-07 国立大学法人 東京医科歯科大学 薬剤送達デバイスおよびその製造方法
JP2023523952A (ja) 2020-04-28 2023-06-08 ティコナ・エルエルシー マイクロニードルアセンブリ
KR102740788B1 (ko) * 2020-07-02 2024-12-09 연세대학교 산학협력단 멀티 레이어 마이크로니들 구조체 및 이의 제조 방법
GB2631618B (en) 2020-07-29 2025-05-14 Biolinq Incorporated Continuous analyte monitoring system with microneedle array
CN118001218B (zh) * 2022-11-08 2026-03-06 沈阳药科大学 一种血糖响应型释药可视化长效微针及其制备方法
CN115998850A (zh) * 2022-12-26 2023-04-25 中山大学 一种尿酸响应性水凝胶微针及其制备方法
CN120857905A (zh) 2023-02-02 2025-10-28 比奥林公司 用于改善基于微针的连续分析物监测系统的传感器灵敏度的方法
WO2024167986A2 (en) * 2023-02-10 2024-08-15 Alj Creative Works, Llc Programmable drug-device microneedle system for the treament of diabetes, obesity, and associated conditions
CN117088903B (zh) * 2023-08-15 2026-03-17 河南师范大学 苯硼酸基两性离子表面活性剂的制备方法及其合成pH响应二聚体分子的应用
CN117159443B (zh) * 2023-10-19 2024-04-19 暨南大学 原位超分子凝胶微针贴片及其制备方法和应用

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005526009A (ja) 2001-12-02 2005-09-02 ノボ　ノルディスク　アクティーゼルスカブ 新規グルコース依存性インスリン
JP2010540507A (ja) 2007-09-28 2010-12-24 ザ クイーンズ ユニヴァーシティ オブ ベルファスト 送達装置および方法
JP2011508786A (ja) 2008-01-04 2011-03-17 バイオデル， インコーポレイテッド 組織グルコースレベルの関数としてのインスリン放出のためのインスリン製剤
WO2014113679A1 (en) 2013-01-18 2014-07-24 The University Of North Carolina At Chapel Hill High-throughput manufacturing of microneedles
US20160157764A1 (en) 2014-12-03 2016-06-09 IMAST scarl Microneedle array device and method of making
JP2016517885A (ja) 2013-04-30 2016-06-20 マサチューセッツ インスティテュート オブ テクノロジー 糖尿病を処置するための注射可能なナノネットワークゲル
WO2016172320A1 (en) 2015-04-21 2016-10-27 North Carolina State University Office Of Technology Transfer Glucose-responsive insulin delivery system using hyoxia-sensitive nanocomposites
WO2018085809A1 (en) 2016-11-07 2018-05-11 North Carolina State University Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery
WO2018106697A1 (en) 2016-12-05 2018-06-14 North Carolina State University H 2o 2-responsive nanoparticles and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1469903A2 (en) * 2001-09-28 2004-10-27 BioValve Technologies, Inc. Microneedle with membrane
WO2010050913A1 (en) 2008-10-31 2010-05-06 The Brigham And Women's Hospital, Inc. Vaccination with poxvirus vectors via mechanical epidermal disruption
WO2013123492A2 (en) 2012-02-17 2013-08-22 Massachusetts Institute Of Technology Glucose-responsive microgels for closed loop insulin delivery
WO2016172554A1 (en) 2015-04-23 2016-10-27 Carnegie Mellon University Biosensor tattoos and uses therefor for biomarker monitoring
DK3548135T3 (da) * 2016-12-05 2021-11-22 Univ North Carolina State Kerne-skal-mikronålsindretninger og anvendelser deraf

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005526009A (ja) 2001-12-02 2005-09-02 ノボ　ノルディスク　アクティーゼルスカブ 新規グルコース依存性インスリン
JP2010540507A (ja) 2007-09-28 2010-12-24 ザ クイーンズ ユニヴァーシティ オブ ベルファスト 送達装置および方法
JP2011508786A (ja) 2008-01-04 2011-03-17 バイオデル， インコーポレイテッド 組織グルコースレベルの関数としてのインスリン放出のためのインスリン製剤
WO2014113679A1 (en) 2013-01-18 2014-07-24 The University Of North Carolina At Chapel Hill High-throughput manufacturing of microneedles
JP2016517885A (ja) 2013-04-30 2016-06-20 マサチューセッツ インスティテュート オブ テクノロジー 糖尿病を処置するための注射可能なナノネットワークゲル
US20160157764A1 (en) 2014-12-03 2016-06-09 IMAST scarl Microneedle array device and method of making
WO2016172320A1 (en) 2015-04-21 2016-10-27 North Carolina State University Office Of Technology Transfer Glucose-responsive insulin delivery system using hyoxia-sensitive nanocomposites
JP2018513874A (ja) 2015-04-21 2018-05-31 ノース カロライナ ステート ユニバーシティＮｏｒｔｈ Ｃａｒｏｌｉｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ 低酸素感受性ナノコンポジットを用いたグルコース応答性インスリン送達システム
WO2018085809A1 (en) 2016-11-07 2018-05-11 North Carolina State University Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery
WO2018106697A1 (en) 2016-12-05 2018-06-14 North Carolina State University H 2o 2-responsive nanoparticles and uses thereof

Also Published As

Publication number Publication date
EP3548135A1 (en) 2019-10-09
DK3548135T3 (da) 2021-11-22
EP3799865A1 (en) 2021-04-07
EP3548135A4 (en) 2020-07-29
CN110167624B (zh) 2021-11-19
WO2018106696A1 (en) 2018-06-14
EP3548135B1 (en) 2021-10-13
CA3045882A1 (en) 2018-06-14
US11697007B2 (en) 2023-07-11
JP2020512283A (ja) 2020-04-23
US20230364402A1 (en) 2023-11-16
EP3799865B1 (en) 2022-06-15
US20190351206A1 (en) 2019-11-21
CN110167624A (zh) 2019-08-23

Similar Documents

Publication Publication Date Title
JP7232526B2 (ja) コアシェル型マイクロニードル装置及びその使用
Wang et al. Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing
Yavuz et al. Silk fibroin microneedle patches for the sustained release of levonorgestrel
Chen et al. Chitosan microneedle patches for sustained transdermal delivery of macromolecules
Xu et al. Microneedles integrated with ZnO quantum-dot-capped mesoporous bioactive glasses for glucose-mediated insulin delivery
Rajput et al. A key role by polymers in microneedle technology: a new era
Chen et al. Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin
US11351230B2 (en) Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery
US20230381096A1 (en) Core-shell microneedle patch for h2o2 and ph cascade-triggered insulin delivery
Golshirazi et al. The synergistic potential of hydrogel microneedles and nanomaterials: breaking barriers in transdermal therapy
US12161749B2 (en) Microneedle-array patches with glucose-responsive matrix for closed-loop insulin delivery
US11331277B2 (en) H2O2-responsive nanoparticles and uses thereof
GhavamiNejad et al. Transdermal drug delivery via microneedle patches
CN117085116A (zh) 一种葡萄糖响应性微针贴片及其制备方法和应用
Class et al. Patent application title: CORE-SHELL MICRONEEDLE DEVICES AND USES THEREOF
Bhatnagar et al. Protein-based microneedles for drug and vaccine delivery
Cobongela Polymers in drug delivery
Bhatnagar et al. for Drug and Vaccine Delivery
HK40033876A (en) Core-shell microneedle patch for h2o2 and ph cascade-triggered insulin delivery
Zhang Bioresponsive Drug Delivery by Microneedle Patches
Farhan Saleh Chitosan blending with water-soluble polymers as dissolving microneedles for controlled drug release

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201022

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201022

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210720

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210803

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211029

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211222

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20220201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220705

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220928

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230117

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230213

R150 Certificate of patent or registration of utility model

Ref document number: 7232526

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150